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A B S T R A C T
A 48-year-old woman was referred to the cardiology department due to a large mobile mass in the right
ventricle. The patient had undergone radical hysterectomy and bilateral salpingo-oophorectomy for a
uterine squamous cell carcinoma approximately 3.5 years before. In order to protect the patient from
circulatory collapse, the intracardiac mass was resected surgically. A diagnosis of cardiac metastasis of
the uterine cervical squamous cell carcinoma was conﬁrmed histologically. Herein we discuss the
possible therapeutic approach to and prognosis of this rare condition by reviewing 24 papers on
intracardiac uterine cancer metastasis published in the past 10 years.
<Learning objective: A woman who had undergone radical hysterectomy and bilateral salpingo-
oophorectomy for a uterine squamous cell carcinoma 3.5 years before was referred to the cardiology
department due to a large mass in the right ventricle. The diagnosis of cardiac metastasis of the uterine
cervical squamous cell carcinoma was conﬁrmed histologically. Although metastasis of cervical
carcinoma to the cardiac cavity is rare, we should not overlook this possibility during the post-operative
patient follow-up.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Metastasis of malignancies into the heart may also develop,
albeit at a low reported frequency of 1.6–8% [1]. This frequency
might be underestimated, however, because cardiac metastasis
often remains clinically silent, leading to a difﬁculty of diagnosis
during life. In fact, cardiac metastasis has been reported to increase
to a frequency of 10–20% among cases with known malignancies
during autopsy [2]. Metastasis of cervical cancer occurs usually to
the liver, bone, brain, lung, and supraclavicular lymph nodes [3]. It* Corresponding author at: Department of Cardiology, Osaka Medical College,
2-7 Daigaku-machi, Takatsuki, Osaka 569-8686, Japan. Tel.: +81 72 683 1221;
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1878-5409/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsmay occur to the heart, although far less frequently. Herein, we
present the case of a 48-year-old woman who was diagnosed
to have metastasis of the cervical cancer into the right ventricle
3.5 years after the resection of the primary lesion.
Case report
A 48-year-old woman was referred to our cardiology depart-
ment for the diagnosis and treatment of a cardiac mass in the right
ventricle. The patient had been diagnosed with cervical cancer four
years before. After chemotherapy by the BOAI (balloon-occluded
arterial infusion) method with cisplatin and CPT-11, the patient
underwent radical hysterectomy and bilateral salpingo-oophorec-
tomy (Table 1) under the diagnosis of cervical cancer (FIGO IIA2). A
post-operation diagnosis of pT2aN1M0 squamous cell carcinoma
was made, and chemoradiation therapy was performed. reserved.
Table 1 Summary of treatments for uterine carcinoma.
Year Month Treatment for the uterine carcinoma
2010 February Diagnosis of uterine cervical squamous cell
carcinoma (stage IIA2)
Preoperative chemotherapy (2 courses: BOAI of
CDDP and CPT-11)
May Radical hysterectomy and bilateral salpingo-
oophorectomy
Postoperative chemotherapy (5 courses: CDDP),
Pelvic radiation therapy
2011 January Radiation for paraaortic lymph node metastasis
June Left supraclavicular lymph node metastasis by
FDG-PET/CT
Chemotherapy (6 courses: CDDP and CPT-11)
2012 March Chemotherapy (9 courses: CBDCA and PTX)
2013 January Radiation to the left supraclavicular lymph nodes
December Tumor marker elevation (SCC 6.2 ng/mL)
18F-FDG uptake in the right ventriculum and
diagnosis of the intracardiac mass
Surgical resection of the intracardiac mass
2014 February Radiation for heart and mediastinal lymph nodes
March Chemotherapy (CBDCA and PTX)
BOAI: balloon-occluded arterial infusion chemotherapy; FDG-PET: ﬂuorodeox-
yglucose-positron emission tomography; CDDP: cisplatin; CPT-11: irinotecan;
CBDCA: carboplatin; PTX: paclitaxel.
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to the left subclavian lymph nodes (1.5 years later) was
subsequently diagnosed after the initial diagnosis, and thus,
chemo- and/or radiation therapy was performed. It was found that
serum levels of a tumor marker, squamous cell carcinoma (SCC)
antigen, were gradually increasing after the initial diagnosis (SCC
6.2 ng/mL 44-months post-operation). Despite searching for
possible tumor recurrence, no obvious local recurrence of
metastasis was evident; therefore 18F-ﬂuorodeoxyglucose
(18F-FDG) positron emission tomography (PET)/computed tomog-
raphy (CT) was performed that illustrated enhanced 18F-FDG
uptake within the right ventricle (RV) (Fig. 1A and B, arrows).
Echocardiography demonstrated a tumorous lesion of
3.7 cm  1.9 cm in the RV, which seemed to be attached to the
free wall of the RV (Fig. 1C, arrow).
On admission, the patient exhibited normal sinus rhythm
(75 beats per minute) and systolic blood pressure (122/75 mmHg).
The patient did not have exertional dyspnea and the blood oxygen
saturation (SpO2) was 98% on room air. On echocardiography, left
ventricular diastolic and systolic dimensions, and left ventricularFig. 1.
Clinical images and electrocardiogram. (A) Whole body 18F-ﬂuorodeoxyglucos
observed (arrow). (B) Transverse section of the PET-computed tomographi
(C) Echocardiography. A tumorous lesion is observed in the right ventricle (a
segments were observed. (E) The CT image showed pulmonary artery emboejection fraction were 41 mm, 25 mm, and 71%, respectively. Right
ventricular was not enlarged, with the dimension of 28 mm 
31 mm. Tricuspid regurgitation was only trivial and the echocar-
diographic estimate of right ventricular systolic pressure was
36.1 mmHg. A chest roentgenogram showed normal cardiac size
and electrocardiography showed normal sinus rhythm with mild
ST-T abnormalities in leads II, III, and aVF (Fig. 1D). No abnormal
cardiac sounds or murmurs could be auscultated. Contrast
enhanced CT showed that peripheral pulmonary artery emboliza-
tion (Fig. 1E, arrows), in addition to the intraventricular mass, and
cardiac magnetic resonance (MR) demonstrated a tumor in the RV
that was attached to the free wall and/or apex. On MR imaging,
contrast enhancement of the tumor was weaker than that of the
myocardium.
Laboratory studies showed a white blood cell count of
5660 cells/mL, a hemoglobin level of 12.1 g/dL, a platelet count
of 74  104 cells/mL, and a C-reactive protein concentration of
0.12 mg/dL; and the D-dimer level was elevated to 2.8 mg/mL.
Coronary angiograms showed no apparent coronary artery
stenosis, but small-diameter arteries that might be feeding the
intraventricular tumor were observed (data not shown).
Under the tentative diagnosis of metastatic cardiac malig-
nancy, a surgical approach was selected for the purpose of
prevention of a further embolic episode, right ventricular
collapse, or sudden death due to the large mass dislodging.
The operation was carried out on cardiopulmonary bypass
through a median sternotomy. The tumor was observed to be
located in the RV, attached to the base of the anterior papillary
muscle of the tricuspid valve (Fig. 2A). The tumor was considered
to have widely invaded the neighboring myocardium; therefore,
it could not be completely resected from the heart. The resected
mass was histologically conﬁrmed as a metastatic squamous cell
carcinoma surrounded by eosinophilic amorphous necrotic
tissue (Fig. 2B and C). The cardio-pulmonary bypass time was
7.3 h and bleeding 40 mL. The length-of-stay in the intensive care
unit was 2 days, and the patient was discharged uneventfully 25
days after the surgery. The patient received radiation therapy
(total dose of 450 Gy) that started 5 weeks after the surgery. In
addition, the patient is receiving chemotherapy (combined
therapy with paclitaxel and carboplatin). At the moment, 5.5
months has passed, without any signiﬁcant events, since the
patient was discharged from our hospital. The patient has been
continuing chemotherapy and is still under careful observation,
because her prognosis with metastatic intracardiac lesions is
considered to be poor.e positron emission tomography (18F-FDG-PET). Increased uptake in the heart was
c (CT) merged image. Increased FDG uptake is observed in the heart (arrow).
rrow). (D) Electrocardiogram obtained on admission. Slight abnormalities in ST-T
lization (arrows) and mass lesion in the right ventricle.
Fig. 2.
Intraoperative photograph in surgeon’s view and histology the resected tumor. (A and B) Intraoperative photograph. The tumor occupied the right ventricular
cavity (A, arrowheads). The surface of the tumor was very fragile and easily broken by forceps (B). (C and D) Histological analysis. Histology of the tumor tissue
sampled from the right ventricle (C). Histology of the cervical cancer resected four years ago (D) showed irregularly shaped nests of non-keratinized squamous
epithelium. The intracardiac tumor was diagnosed to be a metastasis of the uterine squamous cell carcinoma.
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We herein reported a patient who was referred to the
cardiology department due to an intracardiac mass coupled with
elevated levels of tumor marker approximately 3.5 years after
resection of a uterine cervical cell carcinoma. Although the patient
was free from cardiac symptoms, surgical resection of the
intracardiac tumor was performed to avoid sudden death due to
tumor dislocation and subsequent cardiogenic shock.
We performed a PubMed literature search of recent studies
between 2004 January and 2014 January, by entering the search
terms ‘‘uterus’’, ‘‘cancer (or carcinoma)’’, ‘‘heart’’, and ‘‘metastasis’’.
These terms returned 40 articles with possibilities, among which
24 reported a diagnosed case of cardiac metastasis of uterine
cancer [1,4–26] (Table 2). Among these metastasized cancers,
squamous cell carcinoma was the most prevalent (11 cases, 50%);
the other types were leiomyosarcoma 5 (21%), adenocarcinoma 4
(17%), stromal sarcoma 2 (8%), and neuroendocrine carcinoma 1
(4%). The right side of the heart (right atrium, right ventricle, and
tricuspid valve, inferior vena cava, coronary sinus) was the
dominant cardiac region (21 cases [88%]) involved in the uterine
cancer metastasis as compared with the left side of the heart
(2 cases [8%]); in addition, two cases showed metastasis to the
pericardium [12,15]. Among 11 cases of metastasized squamous
cell carcinoma, 10 (91%) showed metastasis to the right side of theheart, and the remaining one showed that to the pericardium. The
fact that the right cardiac chamber was far more susceptible to
metastasis of the carcinomas regardless of the cell type may be
attributed to the ﬁltering role of the pulmonary circulation and the
slower ﬂow in the right chambers [27].
The interval between the therapy for the primary lesion and the
cardiac metastasis varied, and some patients experienced an
interval of 10 years or longer before cardiac metastasis. Surgical
resection, which was not curative in most of instances, was
performed in about two thirds of the cases, and chemotherapy
and/or radiation was performed either with surgery or by itself.
The period between diagnosis of the cardiac metastasis and
death varied between 7 months and more than two years. One
patient with cardiac metastasis of the endometroid adenocarcino-
ma was reported to have remained disease-free for 6.5 years after
cardiac radiation with concurrent chemotherapy [23]. In particu-
lar, regarding metastasis of squamous cell carcinoma, the interval
ranged between a few days and 13 months; thus, the prognosis
after diagnosis of cardiac metastasis seems to be poor. In general,
cardiac metastasis from cervical cancer, albeit very rare, is difﬁcult
to diagnose, and no standard treatment regimen for chemotherapy
currently exists [4].
In our case, pulmonary artery embolization, presumably with
tumor cells, was demonstrated by CT imaging. We selected surgical
resection of the intracardiac mass to avoid acute cardiogenic
Table 2 Cases of intracardiac uterine cervical carcinoma reported in the past 10 years.
Reference Published
year
Age Presentation Surgical
excision
Chemotherapy/radiotherapy Interval to
cardiac metastasis
Histologic type Cardiac metastasis Death from cardiac
metastasis
[4] 2013 32 Exertional dyspnea Yes Chemotherapy (carboplatin
with paclitaxel)
15M Squamous cell carcinoma RA and RV 13M
[5] 2013 39 Arrhythmia nausea, vomiting No (biopsy),
autopsy
Radiotherapy 60Gy 1.9Y Squamous cell carcinoma IVC to RA 8M
[1] 2013 22 Dyspnea palpitation Yes Chemotherapy, radiotherapy 1Y Squamous cell carcinoma Coronary sinus to RA No recurrence
at 6M
[6] 2013 49 Lower extremity swelling Yes No N/A Leiomyosarcoma Tricuspid valve N/A
[7] 2012 56 Right central chest discomfort,
tachycardia, right heart failure
and shock
Yes Chemotherapy 2M Leiomyosarcoma RA N/A
[8] 2011 43 Cerebral infarction without any
sequelae
Yes Chemotherapy 14Y Neuroendocrine carcinoma Pulmonary vein to LA No recurrence
at 2Y
[9] 2010 N/A No symptom at the time of
diagnosis, heart failure within
several months of diagnosis
No (biopsy) Chemotherapy, radiotherapy 4Y Squamous cell carcinoma Tricuspid valve 8M
[10] 2010 64 Lightheadedness No (biopsy) N/A 6M Adenocarcinoma RA N/A
[11] 2009 43 Dyspnea No Chemotherapy warfarin 4Y Leiomyosarcoma LA, RV, LV 1Y
[12] 2008 38 Leg swelling, chest pain,
shortness of breath
No Chemotherapy (paclitaxel) 14M Adenocarcinoma Pericardium 6M
[13] 2009 24 Leg swelling, acute respiratory
distress
Yes Chemotherapy (ifosfamide,
adriamycin), radiotherapy
5M Low-grade endometrial
stromal sarcoma
RA, RV (intravenous
extension via IVC)
No recurrence
at 1Y
[14] 2009 62 Shortness of breath No (biopsy) Palliative care 14M Endometrial adenocarcinoma RV 17 days
[15] 2008 64 Dry cough, dyspnea No Chemotherapy, radiotherapy 6M Squamous cell carcinoma Pericardium 10M
[16] 2007 42 Respiratory distress, chest pain Yes N/A 6M Squamous cell carcinoma RA, RV N/A
[17] 2006 63 Fatigue, dyspnea on exertion Yes N/A 33Y Squamous cell carcinoma PA, RV, tricuspid valve Terminal stage
at 5M
[18] 2006 81 Dyspnea on effort, right heart
failure symptom
No, autopsy No 5Y Squamous cell carcinoma RV 3 days
[19] 2006 55 Asymptomatic Yes Chemotherapy for pulmonary
nodule
6Y Leiomyosarcoma RV 13M
[20] 2006 57 Chest pain, shortness of breath Yes Palliative care 10M Squamous cell carcinoma RA (intravenous
extension via IVC)
2M
[21] 2005 68 Shortness of breath, palpitation,
malaise
Yes Chemotherapy 2Y Squamous cell carcinoma RV 5M
[22] 2005 64 Lower abdominal pain and
distension
Yes Radiotherapy N/A Leiomyosarcoma RA (intravenous
extension via IVC)
N/A
[23] 2005 61 Pedal edema Yes Chemotherapy, radiotherapy N/A Endometrial adenocarcinoma RV 6.8Y
[24] 2005 37 No symptom at the time of
diagnosis
No Chemotherapy, radiotherapy N/A Squamous cell carcinoma RV No recurrence
at 8M
[25] 2004 58 Dyspnea, cough, right chest pain Yes No 3Y Squamous cell carcinoma RV, and PA 4M
[26] 2004 48 Lower abdominal discomfort Yes Chemotherapy 4Y Low-grade endometrial
stromal sarcoma
IVC and RV N/A
RA, RV, LA, LV, PA, IVC indicate right atrium, right ventricle, left atrium, left ventricle, pulmonary artery, and inferior vena cava, respectively. N/A: not assessed.
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thought that reducing the obstruction to the blood ﬂow caused by
the tumor may provide symptomatic relief leading to an
improvement in quality of life, although resection of the
metastasized cardiac tumor is, in general, palliative [16].
Nevertheless, considering the very poor prognosis after cardiac
metastasis [28], the indication of such palliative tumor resection
may not depend solely on the symptoms of the condition.
In summary, here we have reported a patient who had a uterine
squamous cell cancer metastasis to the RV of the heart
approximately 3.5 years after resection of the primary lesion.
Such an intracardiac metastasis seems to occur rarely – only
24 cases of cardiac metastasis of a uterine cancer, including
12 cases of squamous cell carcinoma, have been reported in the
past 10 years. Intracardiac metastasis may remain clinically silent;
therefore, we should be aware of this condition, especially among
patients with elevated tumor markers, as in the present case.
Surgical resection of the intracardiac mass may be selected to avoid
acute cardiogenic collapse; however, considering the poor
prognosis after intracardiac metastasis, the indication of palliative
tumor resection and chemotherapy needs to be carefully assessed
for individual cases.
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